AU2010201836C1 - Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment - Google Patents

Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment Download PDF

Info

Publication number
AU2010201836C1
AU2010201836C1 AU2010201836A AU2010201836A AU2010201836C1 AU 2010201836 C1 AU2010201836 C1 AU 2010201836C1 AU 2010201836 A AU2010201836 A AU 2010201836A AU 2010201836 A AU2010201836 A AU 2010201836A AU 2010201836 C1 AU2010201836 C1 AU 2010201836C1
Authority
AU
Australia
Prior art keywords
treatment
famciclovir
day
lesions
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010201836A
Other languages
English (en)
Other versions
AU2010201836B2 (en
AU2010201836A1 (en
Inventor
Stephan Billstein
Robert Charnas
Spotswood L. Spruance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006230291A external-priority patent/AU2006230291A1/en
Application filed by Novartis AG filed Critical Novartis AG
Priority to AU2010201836A priority Critical patent/AU2010201836C1/en
Publication of AU2010201836A1 publication Critical patent/AU2010201836A1/en
Publication of AU2010201836B2 publication Critical patent/AU2010201836B2/en
Application granted granted Critical
Publication of AU2010201836C1 publication Critical patent/AU2010201836C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2010201836A 2005-03-30 2010-05-06 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment Ceased AU2010201836C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2010201836A AU2010201836C1 (en) 2005-03-30 2010-05-06 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66653705P 2005-03-30 2005-03-30
US60/666,536 2005-03-30
PCT/US2006/011498 WO2006105216A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
AU2006230291A AU2006230291A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
AU2010201836A AU2010201836C1 (en) 2005-03-30 2010-05-06 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2006230291A Division AU2006230291A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Publications (3)

Publication Number Publication Date
AU2010201836A1 AU2010201836A1 (en) 2010-05-27
AU2010201836B2 AU2010201836B2 (en) 2013-05-02
AU2010201836C1 true AU2010201836C1 (en) 2014-07-03

Family

ID=36685678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010201836A Ceased AU2010201836C1 (en) 2005-03-30 2010-05-06 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Country Status (9)

Country Link
US (1) US20110257204A1 (de)
EP (2) EP2394651A1 (de)
JP (1) JP2008534602A (de)
AU (1) AU2010201836C1 (de)
BR (1) BRPI0609592A2 (de)
CA (1) CA2602691A1 (de)
CL (1) CL2006000697A1 (de)
MX (1) MX2007012104A (de)
WO (1) WO2006105216A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RABORN GW and GRACE MG: J Can Dent Assoc, 2003 Sep;69(8):498-503. *
SPRUANCE S et al: Herpes (2002), Vol 9, No 3, pages 64-69 *

Also Published As

Publication number Publication date
BRPI0609592A2 (pt) 2010-04-20
WO2006105216A1 (en) 2006-10-05
AU2010201836B2 (en) 2013-05-02
EP2394651A1 (de) 2011-12-14
JP2008534602A (ja) 2008-08-28
AU2010201836A1 (en) 2010-05-27
MX2007012104A (es) 2008-03-11
CL2006000697A1 (es) 2008-05-09
CA2602691A1 (en) 2006-10-05
US20110257204A1 (en) 2011-10-20
EP1865960A2 (de) 2007-12-19

Similar Documents

Publication Publication Date Title
AU2010201836C1 (en) Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
EP1865961B1 (de) Famciclovir zur behandlung von rezidivierendem herpes labialis mittels einmal-täglich-behandlung
US20120329815A1 (en) Famciclovir for the Treatment of Recurrent Herpes Labialis using a One-Day Treatment
TWI418347B (zh) 治療疱疹病毒感染的方法
GB2282759A (en) Use of acyclovir in treatment of post-herpetic neuralgia
JPH09506883A (ja) 薬 剤

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: ALPHAPHARM PTY LTD

Opponent name: APOTEX PTY LTD

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 04 MAR 2014 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 04 MAR 2014

CH Opposition withdrawn

Opponent name: ALPHAPHARM PTY LTD

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired